Aura Biosciences Inc
NASDAQ:AURA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Aura Biosciences Inc
NASDAQ:AURA
|
US |
|
S
|
Sprott Inc
F:A781
|
CA |
|
URU Metals Ltd
F:NVRA
|
CA |
|
B
|
Bangkok Expressway and Metro PCL
SET:BEM
|
TH |
|
TMX Group Ltd
TSX:X
|
CA |
|
E
|
Everpure Inc
F:6PU
|
US |
|
B
|
Banco Bradesco SA
BMV:BBDN
|
BR |
|
Siemens AG
F:SIE
|
DE |
|
E
|
Enterprise Metals Ltd
F:RM9
|
AU |
Intrinsic Value
There is not enough data to reliably calculate the intrinsic value for Aura Biosciences Inc.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Aura Biosciences Does
Aura Biosciences is a clinical-stage biotechnology company that develops cancer treatments designed to attack tumor cells while sparing healthy tissue. Its lead approach uses a virus-like particle that carries a tumor-targeting drug, then is activated with light to destroy cancer cells in a very precise area. The company is best known for working on eye cancers, especially uveal melanoma, but its broader platform is aimed at solid tumors that can be reached and treated locally.
- Headquarters
- United States of America US
- Employees
- 113
- IPO date
- Oct 29, 2021
